Assignee
XW LAB INC
KY·15 granted patents·605 citations·filing 2016–2020
Top patents by PatentIndex Score
15 records- 0198US10941107B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2020·Granted Mar 9, 2021·36 cites·26 claims
- 0298US10882832B2Bicyclic heteroaryl derivatives and preparation and uses thereofXW LAB INC·Filed 2020·Granted Jan 5, 2021·36 cites·30 claims
- 0398US10774031B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2020·Granted Sep 15, 2020·57 cites·29 claims
- 0498US10640451B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2019·Granted May 5, 2020·52 cites·30 claims
- 0598US10640476B2Bicyclic heteroaryl derivatives and preparation and uses thereofXW LAB INC·Filed 2019·Granted May 5, 2020·36 cites·16 claims
- 0698US10501401B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2019·Granted Dec 10, 2019·60 cites·30 claims
- 0798US10457627B2Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXW LAB INC·Filed 2016·Granted Oct 29, 2019·61 cites·32 claims
- 0897US10968202B2Compounds as neuronal histamine receptor-3 antagonists and uses thereofXW LAB INC·Filed 2020·Granted Apr 6, 2021·38 cites·15 claims
- 0997US10836714B2Ketamine derivatives and compositions thereofXW LAB INC·Filed 2020·Granted Nov 17, 2020·41 cites·30 claims
- 1097US10730853B2Compounds as neuronal histamine receptor-3 antagonists and uses thereofXW LAB INC·Filed 2020·Granted Aug 4, 2020·38 cites·12 claims
- 1197US10683262B2Ketamine derivatives and compositions thereofXW LAB INC·Filed 2019·Granted Jun 16, 2020·40 cites·25 claims
- 1297US10618886B1Compounds as neuronal histamine receptor-3 antagonists and uses thereofXW LAB INC·Filed 2019·Granted Apr 14, 2020·38 cites·12 claims
- 1396US10889572B2Reactive oxygen species scavengers and use for treating diseasesXW LAB INC·Filed 2020·Granted Jan 12, 2021·36 cites·25 claims
- 1496US10858394B2Preparation and uses of reactive oxygen species scavenger derivativesXW LAB INC·Filed 2020·Granted Dec 8, 2020·36 cites·14 claims
- 1563US11149006B2Compounds as neurokinin-1 receptor antagonists and uses thereofXW LAB INC·Filed 2020·Granted Oct 19, 2021·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when XW LAB INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →